A Pilot Study of Dacomitinib With or Without Osimertinib for Patients With Metastatic EGFR Mutant Lung Cancers With Disease Progression on Osimertinib.
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
University of California, Irvine
University of Southern California
Ohio State University Comprehensive Cancer Center
Mayo Clinic
Wake Forest University Health Sciences
Brigham and Women's Hospital
University of Edinburgh
Centre hospitalier de l'Université de Montréal (CHUM)
Centre hospitalier de l'Université de Montréal (CHUM)
Duke University
Siemens Molecular Imaging
Siemens Molecular Imaging